Global Immunology Market Analysis - Industry Trends, Market Size, and Forecast to 2024
Global Immunology Market Report 2019 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Immunology industry.
View Full Report :
The report provides key statistics on the market status of the Immunology manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
Get Sample Copy Of This Report @
There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.
For competitor segment, the report includes global key players of Immunology as well as some small players. At least 8 companies are included:
* F. Hoffmann-La Roche
* Johnson & Johnson
* Bionor Pharma
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Immunology market
* Immuno Boosters
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Autoimmune Diseases
* Organ Transplantation
For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report covers following regions:
* North America
* South America
* Asia & Pacific
* MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
Avail Discount On This Report @
For U.S. Toll Free Call +1 (425) 388-2538
For IST Call +91-8040957137
Source: Valuates Reports
To know more visit us on:
Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of silicon valley of India (Bengaluru) and provide 24/7 online and offline support to all our customers and just a phone call away.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Immunology Market Analysis - Industry Trends, Market Size, and Forecast to 2024 here
News-ID: 1774436 • Views: 678
More Releases from Valuates Reports
Impact of COVID-19 on Global IT Industry (pre-order)
The COVID-19 outbreak has imposed a significant impact on the global IT industry, affecting both the supply and demand sides. The global economy has entered a recession in 2020. This report looks into major countries’ countermeasures, enterprises’ supporting strategies, suppliers’ operations after suspension, and changes in consumer demand to analyze the impact of COVID-19 on the entire IT industry, mainly the PC, notebook PC, and server sectors. View Full Report: https://reports.valuates.com/market-reports/MICR-Cons-4O14/impact-of-covid19-on List
Global and Taiwan IT Hardware Industry Year Book
According to Market Intelligence & Consulting Institute (MIC) of the Institute for Information Industry (III), shipment value of the global IT hardware industry – mainly comprising of notebook PC, desktop PC, motherboard, and server - totaled about US$ 171.2 billion in 2019, down 0.8% compared to 2018. The ongoing US-China trade war continued to have its toll on the IT market and industry in 2019. In 2020, the COVID-19 outbreak
mRNA Treatment Market Size, Share, Trends, Growth, Forecast | Valuates Reports
mRNA Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-22U2563/covid-19-impact-on-global-mrna-treatment Since the COVID-19 virus outbreak in December
Plasma Fractionation Market Report, Size, Growth, Trends, Segments, Forecast | V …
In 2018, the global Plasma Fractionation market size was 24600 million US$ and it is expected to reach 32300 million US$ by the end of 2025, with a CAGR of 4.0% during 2019-2025. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-4176/Global_Plasma_Fractionation Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation. Plasma Fractionation is
More Releases for Immuno
Next Gen Immuno-Oncology Congress - 4th Annual MarketsandMarkets
In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction. Register as a Delegate at https://www.reportsnreports.com/events/4th-annual-marketsandmarkets-next-gen-immuno-oncology-congress/register o 30+ experts from academia and industry will be presenting their current work in Immuno-Oncology, Latest updates on
Cell Therapy to Transform Immuno Oncology Landscape
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Immuno Oncology Assays Market Expected to Dominate Worldwide by 2026
Global Immuno Oncology Assays Market Analysis According to Verified Market Research, The Global Immuno Oncology Assays Market was valued at USD 2.76 Billion in 2018 and is projected to reach USD 6.96 Billion by 2026, growing at a CAGR of 12.19% from 2019 to 2026. What is Immuno Oncology Assays? Immuno oncology assays is a next-generation sequencing application that provides real-time automated measurements of immune and tumor cells dynamics. With the help of
Immuno-Oncology Conference, London – agenda released
Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies. SMi's Immuno-Oncology Conference (26 – 27 September 2018, London, UK) will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress. Agenda - Valuable time is spent to
Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis
Latest industry research report on: Immuno-Oncology Strategic Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion by 2024 in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). The main drivers of this growth will come from immune checkpoint inhibitors, which will have sales of approximately
Immuno-Oncology Market Stood at US$ 27,846.3 Mn by 2025
PMR is its report has profiled some of the leading companies operating in the global immuno-oncology market, which includes Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb, Dendreon Corporation, F.Hoffmann-La Roche, Merck & Co., Inc. Novartis AG, Pfizer, Inc., Sanofi. In terms of revenue share, Bristol-Myers Squibb (BMS) was ranked at the top in 2016, thanks to the success of its blockbuster products Opdivo and Yervoy. Owing to higher efficiency as compared to